Literature DB >> 8002999

Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.

H Yamamoto1, F Itoh, Y Hinoda, A Senota, M Yoshimoto, H Nakamura, K Imai, A Yachi.   

Abstract

Matrilysin is believed to have a role in tumor progression. Its expression correlates with the occurrence of colorectal cancer. We have examined the expression of matrilysin mRNA in various colorectal disorders and its localization using RT-PCR and in situ hybridization. We have also examined whether Matrilysin is induced by cell to matrix interaction. Matrilysin mRNA was detected in all adenoma tissues examined, whereas none was detectable in hyperplastic polyps, mildly inflamed regions of ulcerative colitis or normal colon tissues, and its message was localized in adenoma cells themselves. In addition, levels of enzyme activities of matrilysin were lower in adenomas compared with cancers in casein zymography. Matrilysin mRNA was induced by immobilized truncated fibronectin or RGD peptide. Thus, matrilysin may play an important role in colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8002999     DOI: 10.1006/bbrc.1994.1751

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

Authors:  C L Wilson; K J Heppner; P A Labosky; B L Hogan; L M Matrisian
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

2.  Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.

Authors:  A A Thant; A Nawa; F Kikkawa; Y Ichigotani; Y Zhang; T T Sein; A R Amin; M Hamaguchi
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Induction of matrix metalloprotease-7 is common in mucinous ovarian tumors including early stage disease.

Authors:  K Shigemasa; H Tanimoto; K Sakata; N Nagai; T H Parmley; K Ohama; T J O'Brien
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

4.  Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.

Authors:  Y Adachi; H Yamamoto; F Itoh; Y Hinoda; Y Okada; K Imai
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

5.  Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer.

Authors:  A Senota; F Itoh; H Yamamoto; Y Adachi; Y Hinoda; K Imai
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

6.  Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.

Authors:  K Lampert; U Machein; M R Machein; W Conca; H H Peter; B Volk
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

7.  Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.

Authors:  Elke Roeb; Marlies Arndt; Bettina Jansen; Volker Schumpelick; Siegfried Matern
Journal:  Int J Colorectal Dis       Date:  2004-04-22       Impact factor: 2.571

Review 8.  Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis.

Authors:  J R MacDougall; L M Matrisian
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

9.  Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.

Authors:  Heui-Young Ryu; Jiseon Lee; Sanghwa Yang; Haein Park; Sojoong Choi; Kyeong-Cheon Jung; Seung-Taek Lee; Je-Kyung Seong; Inn-Oc Han; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

10.  Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.

Authors:  K J Heppner; L M Matrisian; R A Jensen; W H Rodgers
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.